Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CLLS US Equity

Cellectis S.A.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1627281 · FY ends Dec 31
$3.17
+0.13 (+4.28%)
USD · as of 2026-08-19 · marketstack

Legal & controls

No original 10-K is on record for this name in the filings index. Foreign filers (20-F / ESEF / EDINET) file no 10-K and therefore have no Item 3 or Item 9A to read.